New Children's Hospital, Department of Pediatric Surgery, Helsinki University Hospital and University of Helsinki, Stenbäckinkatu 9, 00029 HUS, Helsinki, Finland.
New Children's Hospital, Department of Pediatric Surgery, Helsinki University Hospital and University of Helsinki, Stenbäckinkatu 9, 00029 HUS, Helsinki, Finland; Rare Disease Centre, Department of Pediatric Surgery, Helsinki University Hospital and University of Helsinki, Finland; VASCERN VASCA European Reference Centre, Stenbäckinkatu 9, 00029 HUS, Helsinki, Finland.
J Pediatr Surg. 2022 Dec;57(12):1005-1010. doi: 10.1016/j.jpedsurg.2022.07.024. Epub 2022 Aug 2.
Lymphatic malformations (LMs) are benign, congenital lesions that display considerable heterogeneity in terms of size, location and characteristics. This study aims to describe the long-term outcomes of current management strategies for patients with simple (cystic) LMs.
The case records of all patients (age ≤16 years) with simple (cystic) LMs at our tertiary institution between 2008 and 2019 were assessed for clinical features, imaging and details of management, including complications.
Of a total of 164 patients (60% male), 66% were diagnosed aged <2 years. The median follow-up was 5 (0.3-16) years from diagnosis. LMs were located in the head and neck (40%), extremities (27%), trunk (23%), mediastinum (4%), or intra-abdominally (6%). Types were macrocystic in 47%, microcystic in 21% and mixed in 32%. Sclerotherapy was the most common intervention (38%). Primary surgery had been performed in 12%. Symptomatic improvement, reduction in size, or complete regression were observed in 82/102 (80%) of LMs after interventions; complications from treatment were uncommon (Clavien-Dindo grade I-II: 6%; grade III-IIId: 1%). Sixty-two patients (38%; median age 0.5 (range, 0-12) years) had not required interventions to date; spontaneous regression of the LM occurred in 16 (26%) of these expectantly followed-up cases.
Most studies to date have focused on LMs in selected anatomical locations. Herein the outcomes of an entire population from a single tertiary unit of patients are presented, demonstrating the wide heterogeneity of simple (cystic) LMs and highlighting the importance of individualized, multidisciplinary approaches to care in achieving optimal outcomes.
淋巴管畸形(LMs)是良性先天性病变,在大小、位置和特征方面具有显著异质性。本研究旨在描述目前治疗单纯(囊性)LM 患者的管理策略的长期结果。
评估了 2008 年至 2019 年期间我院三级机构中所有单纯(囊性)LM 患者(年龄≤16 岁)的病例记录,包括临床特征、影像学和管理细节,包括并发症。
共有 164 例患者(60%为男性),66%在<2 岁时被诊断。从诊断到中位随访时间为 5 年(0.3-16 年)。LM 位于头颈部(40%)、四肢(27%)、躯干(23%)、纵隔(4%)或腹腔内(6%)。47%为巨囊型,21%为微囊型,32%为混合性。硬化治疗是最常见的干预措施(38%)。12%曾行初次手术。干预后,102 例 LM 中有 82 例(80%)观察到症状改善、体积缩小或完全消退;治疗相关并发症不常见(Clavien-Dindo 分级 I-II:6%;III-IIId 级:1%)。62 例(38%;中位年龄 0.5 岁(范围,0-12 岁))至今未行干预措施;这些预期随访的病例中有 16 例(26%)出现 LM 自发消退。
迄今为止,大多数研究都集中在特定解剖部位的 LMs。本研究报告了来自单个三级机构的整个患者群体的结果,展示了单纯(囊性)LM 的广泛异质性,并强调了采用个体化、多学科方法进行治疗以获得最佳结果的重要性。